ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,239.19
0.72%
S&P 500
5,416.24
-0.32%
Dow Jones
38,443.49
-0.53%
US Dollar vs Yen
157.3125
0.12%
Brent Oil
82.945
1.18%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) ニュース

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TNXP
日付受信時刻ニュースソース見出しコード企業名
2024/06/1406 : 24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1406 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1306 : 01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1222 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1206 : 17GlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1205 : 49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/1021 : 53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0700 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0700 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock SplitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0621 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0621 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0521 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0321 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/06/0321 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/3021 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/3021 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2921 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2821 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International ConventionNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2506 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2506 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2506 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2506 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2306 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2221 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2221 : 00GlobeNewswire Inc.Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2121 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/2121 : 00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/1521 : 00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/1405 : 56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/05/1405 : 56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

最近閲覧した銘柄

CCOM
US500
US 500
NYSE
AXP
American Express
FX
USDEUR
US Dollar vs Euro
CCOM
US100
US Tech 100
FX
USDJPY
US Dollar vs Yen
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有